APP Pharmaceuticals Reports 2008 First Quarter Net Revenues of $148 Million, Gross Profit of $70 Million

SCHAUMBURG, Ill.--(BUSINESS WIRE)--APP Pharmaceuticals, Inc. (Nasdaq:APPX), a leading manufacturer of multi-source and branded injectable pharmaceutical products, today reported financial results for the first quarter ended March 31, 2008. As a result of the separation of Abraxis BioScience from APP Pharmaceuticals, APP’s business is reported, for all periods presented, on a continuing operations basis and Abraxis BioScience’s business is reported in discontinued operations.